Table 2: Most encountered complications: the results are shown as number of NSM performed or number of patients. The values in parenthesis refer to the percentage values.
Reference |
Complications |
Number, (%) |
Grobmyer et al. [17] |
Nr |
Nr |
Radovanovic et al. [18] |
Capsular contracture Infection Seroma Mayor cutaneous necrosis Minor cutaneous necrosis Hematoma Local recurrences |
33/441 (7,5) 15/441 (3,4) 13/441 (2,9) 12/441 (2,7) 11/441 (2,5) 3/441 (0,7) 2/441 (0,5) 1/441 (0,2) 32/441 (7,3) |
Dull et al. [19] |
Necrosis Hematoma Pulmonary edema Seroma |
12/34 (35,3) 11/34 (32,3) 5/34 (14,7) 2/34 (5,9) 1/34 (2,9) |
Shimo et al. [20] |
Necrosis |
6/425 (1,4) 25/425 (5,8) |
Moo et al. [21] |
Local recurrences Distant recurrences Local and distant recurrences |
8/368 (2,2) 9/368 (2,4) 6/368 (1,6) |
Manning et al. [22] |
Necrosis Infection Hematoma |
13/177 (7,3) 4/177 (4,0) 3/177 (1,7) |
Yao et al. [23] |
Necrosis NAC loss |
10/397 (2,5) 7/397 (1,8) |
Voltura et al. [24] |
Local recurrences |
2/36 (5,5) |
Crowe et al. [25] |
NAC partial loss Infection |
2/110 (1,8) 1/110 (0,9) |
Petit et al. [26] |
NAC total necrosis Partial necrosis Infections Local recurrences |
26/773 (3,4) 49/773 (6,3) 13/773 (1,7) 12/773 (1,5) |
Sacchini et al. [27] |
Necrosis Local recurrence |
22/192 (11,4) 2/192 (1,0) |
Crowe et al. [28] |
Nr |
Nr |
Nr: Not reported; NAC: Areola-Nipple Compound.